News & Analysis - CNBC

  1. Why Trump reversed course to fast-track psychedelic drugs for mental healthcare

  2. U.S. and Iran still without deal to end war after Trump says he's not in a 'hurry'

  3. Former Barclays CEO Jes Staley agrees to July 23 interview about Jeffrey Epstein by Oversight panel

  4. Disney is poised to ramp its already booming advertising business. Rita Ferro is behind the push

  5. In deeply red Oklahoma, minimum wage’s biggest 2026 election cycle fight is about to be decided

  6. Top Wall Street analysts see robust growth potential in these 3 stocks

  7. Defense spending, China in Asia and lessons from Ukraine: Takeways from the 2026 IISS Shangri-La Dialogue

  8. Oil exports through the Strait of Hormuz might not return to levels seen before the Iran war

  9. Travelers to Europe may be leaving money on the table. Here's why

  10. Student loan borrowing is 'high stakes' as new rules take effect on July 1, CFP says. What to know

  11. Analysis: An end to the Iran war may be just the beginning of a new era of U.S. inequality

  12. Meta has struggled at selling anything other than ads. Will AI be different?

  13. Eva Longoria says this quality is more important than an Ivy League education: 'Do you have the capacity to figure it out?'

  14. SoftBank plans 75 billion euros of AI investments in France, as Europe struggles to catch up with U.S. and China

  15. Josh Brown, counting on a new momentum strategy, thinks investors want more than index funds

  16. My guide to the IPOs of SpaceX, OpenAI and Anthropic — including the one I really want to buy

  17. DOJ seeks Judge Eleanor Ross recusal in Georgia election case, citing reports she was disciplined

  18. At least 3.5 million people have lost food stamp access as Trump's 'big beautiful bill' cuts take effect, analysis finds

  19. I climbed the vertical height of Mount Everest in 36 hours—it turned me into 'a new version of myself'

  20. Two months, $2.6 billion: How NASA ETF turned SpaceX IPO access into a hot retail trade